rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18
Income
Operating income 658.29 599.55 433.42 424.16 294.66
Expenses
Material consumed 377.59 337.91 243.03 236.34 169.35
Manufacturing expenses 11.27 10.90 8.95 8.22 7.02
Personnel expenses 60.46 54.64 48.51 46.33 45.86
Selling expenses - - - - -
Adminstrative expenses 95.25 82.38 61.43 69.94 43.29
Expenses capitalised - - - - -
Cost of sales 544.57 485.84 361.93 360.83 265.52
Operating profit 113.72 113.71 71.49 63.33 29.15
Other recurring income 42.25 31.16 0.17 7.93 7.43
Adjusted PBDIT 155.97 144.87 71.66 71.26 36.57
Financial expenses 3.80 5.34 7.29 6.56 7.67
Depreciation 17.66 15.19 11.64 8.69 12.25
Other write offs - - - - -
Adjusted PBT 134.51 124.33 52.73 56.01 16.65
Tax charges 30.52 25.95 14.82 12.39 4.23
Adjusted PAT 103.99 98.38 37.90 43.62 12.43
Non recurring items 0.05 -0.20 0.16 0.03 0.12
Other non cash adjustments - - - - -
Reported net profit 104.03 98.19 38.07 43.65 12.55
Earnigs before appropriation 165.44 65.50 -24.67 -60.69 -100.88
Equity dividend 10.23 4.09 2.47 2.05 2.46
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 155.21 61.41 -27.14 -62.74 -103.34

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close